Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
$33.74
+7.9%
$28.82
$13.70
$34.14
$62.31B0.972.47 million shs6.11 million shs
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
C$0.04
C$0.04
C$0.04
C$0.21
C$9.30M2.64256,268 shs24,000 shs
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
C$0.19
-3.8%
C$0.13
C$0.01
C$0.15
C$27.52M1.13626,457 shs182,470 shs
Zomedica Corp. stock logo
ZOM
Zomedica
$0.12
$0.09
$0.16
$95.35M1.034.72 million shs790,936 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
+2.67%+3.74%+12.50%+24.11%+83.65%
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
0.00%0.00%0.00%0.00%0.00%
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
-1.25%-21.00%+464.29%+3,850.00%+119.44%
Zomedica Corp. stock logo
ZOM
Zomedica
0.00%0.00%0.00%0.00%-34.12%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
2.8088 of 5 stars
0.03.00.80.03.10.03.1
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
N/AN/AN/AN/AN/AN/AN/AN/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
N/AN/AN/AN/AN/AN/AN/AN/A
Zomedica Corp. stock logo
ZOM
Zomedica
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
2.86
Moderate BuyN/AN/A
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
0.00
N/AN/AN/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
0.00
N/AN/AN/A
Zomedica Corp. stock logo
ZOM
Zomedica
4.00
Strong BuyN/AN/A

Current Analyst Ratings Breakdown

Latest KHRN, DB, ZOM, and WLLW Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/10/2025
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageBuy
4/30/2025
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
Cfra Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeModerate Sell ➝ Hold
(Data available from 7/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
$71.84B0.94$3.25 per share10.38$44.47 per share0.76
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
C$18.08M0.51C$0.01 per share6.67C$0.20 per share0.20
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
C$2.94M9.35C$0.23 per share0.83C$0.00 per share137.52
Zomedica Corp. stock logo
ZOM
Zomedica
$25.19M0.00N/AN/A$0.24 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
$4.70B$1.6820.0810.850.405.76%4.61%0.27%7/24/2025 (Estimated)
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
-C$46.80M-C$0.20N/AN/A-258.92%-68.62%-20.79%N/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
-C$7.92M-C$0.05N/AN/A-268.91%-602.73%-74.79%N/A
Zomedica Corp. stock logo
ZOM
Zomedica
-$34.53M-$0.06N/AN/AN/A-232.88%-12.47%-11.84%N/A

Latest KHRN, DB, ZOM, and WLLW Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/24/2025Q2 2025(Pre Recorded)
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
$0.83$0.54-$0.29$0.54$7.80 billionN/A
4/29/2025Q1 2025 Prepared Remarks
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
$0.85$1.04+$0.19$1.04$7.95 billion$8.97 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
N/AN/AN/AN/A4 Years
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
N/AN/AN/AN/AN/A
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
N/A7.35%N/AN/AN/A
Zomedica Corp. stock logo
ZOM
Zomedica
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
1.39
0.79
0.79
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
6.68
3.08
0.72
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
902.05
0.80
19.71
Zomedica Corp. stock logo
ZOM
Zomedica
N/A
10.82
10.15

Institutional Ownership

CompanyInstitutional Ownership
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
27.90%
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
0.22%
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
0.10%
Zomedica Corp. stock logo
ZOM
Zomedica
8.95%
CompanyEmployeesShares OutstandingFree FloatOptionable
Deutsche Bank Aktiengesellschaft stock logo
DB
Deutsche Bank Aktiengesellschaft
89,7531.99 billionN/AOptionable
Khiron Life Sciences Corp. stock logo
KHRN
Khiron Life Sciences
N/A232.41 millionN/ANot Optionable
Willow Biosciences Inc. stock logo
WLLW
Willow Biosciences
19144.85 millionN/ANot Optionable
Zomedica Corp. stock logo
ZOM
Zomedica
50979.95 million938.89 millionNot Optionable

Recent News About These Companies

15 Cheapest Stocks Insiders Are Buying In March
Q4 2024 Zomedica Corp Earnings Call
Zomedica Corp. (ZOMDF) Q4 2024 Earnings Call Transcript
Zomedica (ZOMDF) Gets a Buy from Noble Financial
Zomedica Corp.

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Deutsche Bank Aktiengesellschaft stock logo

Deutsche Bank Aktiengesellschaft NYSE:DB

$33.74 +2.46 (+7.86%)
Closing price 03:59 PM Eastern
Extended Trading
$33.79 +0.05 (+0.15%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Deutsche Bank Aktiengesellschaft, a stock corporation, provides corporate and investment banking, and asset management products and services to private individuals, corporate entities, and institutional clients in Germany, the United Kingdom, rest of Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through Corporate Bank, Investment Bank, Private Bank, and Asset Management segments. The Corporate Bank segment offers cash management, trade finance and lending, trust and agency, and securities services, as well as risk management solutions. The Investment Bank segment provides debt origination, merger and acquisitions, foreign exchange, and equity advisory and origination platform services. The Private Bank segment offers payment and account services, and credit and deposit products, as well as investment advice products, such as environmental, social, and governance products. This segment also provides banking, wealth management, other financial, and postal and parcel services; and supports in planning, managing and investing wealth, financing personal and business interests, and servicing institutional and corporate needs. The Asset Management segment offers investment solutions, such as alternative investments, which include real estate, infrastructure, liquid real assets, and sustainable investments; and various other services, including insurance and pension solutions, asset liability management, portfolio management solutions, and asset allocation advisory to individuals and institutions. Deutsche Bank Aktiengesellschaft was founded in 1870 and is headquartered in Frankfurt am Main, Germany.

Khiron Life Sciences stock logo

Khiron Life Sciences CVE:KHRN

C$0.04 0.00 (0.00%)
As of 05/5/2023

Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.

Willow Biosciences stock logo

Willow Biosciences TSE:WLLW

C$0.19 -0.01 (-3.80%)
As of 07/23/2025

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

Zomedica stock logo

Zomedica NYSEAMERICAN:ZOM

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.